Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Primär kutanes diffus-großzelliges B-Zell-Lymphom, NOS oder leg type: klinische, morphologische und prognostische Unterschiede.

Felcht M, Klemke CD, Nicolay JP, Weiss C, Assaf C, Wobser M, Schlaak M, Hillen U, Moritz R, Tantcheva-Poor I, Nashan D, Beyer M, Dippel E, Müller CSL, Sachse MM, Meiss F, Géraud C, Marx A, Goerdt S, Geissinger E, Kempf W.

J Dtsch Dermatol Ges. 2019 Mar;17(3):275-286. doi: 10.1111/ddg.13773_g.

PMID:
30920753
2.

Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences.

Felcht M, Klemke CD, Nicolay JP, Weiss C, Assaf C, Wobser M, Schlaak M, Hillen U, Moritz R, Tantcheva-Poor I, Nashan D, Beyer M, Dippel E, Müller CSL, Sachse MM, Meiss F, Géraud C, Marx A, Goerdt S, Geissinger E, Kempf W.

J Dtsch Dermatol Ges. 2019 Mar;17(3):275-285. doi: 10.1111/ddg.13773. Epub 2019 Mar 9.

PMID:
30851152
3.

Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.

Maurer M, Raap U, Staubach P, Richter-Huhn G, Bauer A, Oppel EM, Hillen U, Baeumer D, Reinhardt M, Chapman-Rothe N.

Clin Exp Allergy. 2019 May;49(5):655-662. doi: 10.1111/cea.13309. Epub 2018 Dec 7.

PMID:
30415478
4.

Adenoidzystisches Karzinom der Kopfhaut imitiert dermales Zylindrom: Histologie der Gesamtexzision als Schlüssel zur Diagnose.

Rütten A, Hegenbarth W, Kohl PK, Hillen U, Redler S.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1016-1018. doi: 10.1111/ddg.13600_g. No abstract available.

PMID:
30094931
5.

Primary cutaneous adenoid cystic carcinoma mimicking dermal cylindroma: histology of the complete surgical excision as the key to diagnosis.

Rütten A, Hegenbarth W, Kohl PK, Hillen U, Redler S.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1016-1018. doi: 10.1111/ddg.13600. No abstract available.

PMID:
30094921
6.

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.

Hillen U, Leiter U, Haase S, Kaufmann R, Becker J, Gutzmer R, Terheyden P, Krause-Bergmann A, Schulze HJ, Hassel J, Lahner N, Wollina U, Ziller F, Utikal J, Hafner C, Ulrich J, Machens HG, Weishaupt C, Hauschild A, Mohr P, Pföhler C, Maurer J, Wolff P, Windemuth-Kieselbach C, Schadendorf D, Livingstone E; Dermatologic Cooperative Oncology Group (DeCOG).

Eur J Cancer. 2018 Jun;96:34-43. doi: 10.1016/j.ejca.2018.01.075. Epub 2018 Apr 14.

PMID:
29665511
7.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-123. doi: 10.1111/ddg.13401_g. No abstract available.

PMID:
29314698
8.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-122. doi: 10.1111/ddg.13401. Epub 2017 Dec 27. No abstract available.

PMID:
29280595
9.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372_g. No abstract available.

PMID:
29228489
10.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372. Epub 2017 Nov 28. No abstract available.

PMID:
29193659
11.

Ulcerating Herpes Simplex Infection.

Dissemond J, Hillen U, Esser S.

Dtsch Arztebl Int. 2017 Sep 4;114(35-36):604. doi: 10.3238/arztebl.2017.0604b. No abstract available.

12.

[Diagnostics of primary cutaneous lymphomas].

Felcht M, Hillen U, Klemke CD.

Hautarzt. 2017 Sep;68(9):696-701. doi: 10.1007/s00105-017-4020-6. Review. German.

PMID:
28779267
13.

[Importance of cutaneous lymphomas in clinical practice].

Klemke CD, Hillen U, Grabbe S.

Hautarzt. 2017 Sep;68(9):680-681. doi: 10.1007/s00105-017-4026-0. German. No abstract available.

PMID:
28770284
14.

Food-induced anaphylaxis and cofactors - data from the anaphylaxis registry.

Worm M, Scherer K, Köhli-Wiesner A, Ruëff F, Mahler V, Lange L, Treudler R, Rietschel E, Szepfalusi Z, Lang R, Rabe U, Reese T, Schwerk N, Beyer K, Hompes S, Bircher A, Przybilla B, Hawranek T, Hansen G, Friedrichs F, Merk H, Tenbrock K, Lehmann S, Gerstlauer M, Kleine-Tebbe J, Niggemann B, Dickel H, Bücheler M, Bieber T, Hanfland J, Schmitt-Grohe S, Vlajnic D, Heckmann V, Nemat K, Schäkel K, Nordwig A, Schuster A, Schweitzer-Krantz S, Hillen U, Kopp M, Szliska C, Klinge J, Neustädter I, Fuchs T, Bruns R, Marsch C, Kreft B, Coors E, Rebien W, Wedi B, Pföhler C, Rett M, Henzgen M, Vöhringer P, Fölster-Holst R, Hunzelmann N, Siebenhaar G, Nestoris S, Schirpke C, Grabbe J, Stichtenoth G, Ring J, Brockow K, Brehler R, Yildiz I, Volkmuth S, Geißler M, Polz M, Riffelmann F, Thies S, Lepp U, Rabe U, Rebmann H, Spindler T, Klimek L, Pfaar O, Brosi W, Aberer W, Varga E, Reider N, Huttegger I, Kinaciyan T, Hoffmann-Sommergruber K, Eng P, Helbling A, Eigenmann P, Guggenheim R, Schmid-Grendelmeier P.

Allergol Select. 2017 Aug 4;1(1):21-27. doi: 10.5414/ALX01401E. eCollection 2017.

15.

Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.

Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, Pföhler C, Staubach P, Treudler R, Wedi B, Magerl M.

J Allergy Clin Immunol. 2018 Feb;141(2):638-649. doi: 10.1016/j.jaci.2017.06.032. Epub 2017 Jul 24.

PMID:
28751232
16.

Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.

Oschlies I, Kohler CW, Szczepanowski M, Koch K, Gontarewicz A, Metze D, Hillen U, Richter J, Spang R, Klapper W.

J Invest Dermatol. 2017 Nov;137(11):2450-2453. doi: 10.1016/j.jid.2017.06.016. Epub 2017 Jul 3. No abstract available.

17.

SF3B1 and BAP1 mutations in blue nevus-like melanoma.

Griewank KG, Müller H, Jackett LA, Emberger M, Möller I, van de Nes JA, Zimmer L, Livingstone E, Wiesner T, Scholz SL, Cosgarea I, Sucker A, Schimming T, Hillen U, Schilling B, Paschen A, Reis H, Mentzel T, Kutzner H, Rütten A, Murali R, Scolyer RA, Schadendorf D.

Mod Pathol. 2017 Jul;30(7):928-939. doi: 10.1038/modpathol.2017.23. Epub 2017 Apr 14.

18.

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.

Cosgarea I, Ugurel S, Sucker A, Livingstone E, Zimmer L, Ziemer M, Utikal J, Mohr P, Pfeiffer C, Pföhler C, Hillen U, Horn S, Schadendorf D, Griewank KG, Roesch A.

Oncotarget. 2017 Jun 20;8(25):40683-40692. doi: 10.18632/oncotarget.16542.

19.

Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.

Ralser DJ, Basmanav FB, Tafazzoli A, Wititsuwannakul J, Delker S, Danda S, Thiele H, Wolf S, Busch M, Pulimood SA, Altmüller J, Nürnberg P, Lacombe D, Hillen U, Wenzel J, Frank J, Odermatt B, Betz RC.

J Clin Invest. 2017 Apr 3;127(4):1485-1490. doi: 10.1172/JCI90667. Epub 2017 Mar 13.

20.

Stellungnahme der Deutschen --Kontaktallergie-Gruppe (DKG) und der Deutschen Dermatologischen Gesellschaft (DDG) zu haftungsrechtlichen Konsequenzen bei der Epikutantestung mit patienteneigenem Material.

Mahler V, Dickel H, Diepgen TL, Hillen U, Geier J, Kaufmann R, Kreft B, Schnuch A, Szliska C, Bender A.

J Dtsch Dermatol Ges. 2017 Feb;15(2):202-204. doi: 10.1111/ddg.12898_g. No abstract available.

PMID:
28214303
21.

H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.

Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Ruëff F, Jakob T, Yazdi AS, Mahler V, Wagner N, Lippert U, Hillen U, Schwinn A, Pawlak M, Behnke N, Chaouche K, Chapman-Rothe N.

Clin Exp Allergy. 2017 May;47(5):684-692. doi: 10.1111/cea.12900. Epub 2017 Mar 2.

PMID:
28160338
22.

Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.

Möller I, Murali R, Müller H, Wiesner T, Jackett LA, Scholz SL, Cosgarea I, van de Nes JA, Sucker A, Hillen U, Schilling B, Paschen A, Kutzner H, Rütten A, Böckers M, Scolyer RA, Schadendorf D, Griewank KG.

Mod Pathol. 2017 Mar;30(3):350-356. doi: 10.1038/modpathol.2016.201. Epub 2016 Dec 9.

23.

Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.

Hesse K, Satzger I, Schacht V, Köther B, Hillen U, Klode J, Schaper K, Gutzmer R.

Dermatology. 2016;232(5):558-565. doi: 10.1159/000450920. Epub 2016 Nov 23.

24.

[Cutaneous squamous cell carcinoma].

Leiter U, Gutzmer R, Alter M, Ulrich C, Lonsdorf AS, Sachse MM, Hillen U.

Hautarzt. 2016 Nov;67(11):857-866. Review. German.

PMID:
27680009
25.

Statement of the German Contact Dermatitis Research Group (DKG) and the German Dermatological Society (DDG) on liability issues associated with patch testing using a patient's own materials.

Mahler V, Dickel H, Diepgen TL, Hillen U, Geier J, Kaufmann R, Kreft B, Schnuch A, Szliska C, Bender A.

J Dtsch Dermatol Ges. 2017 Feb;15(2):202-204. doi: 10.1111/ddg.12898. Epub 2016 Oct 28. No abstract available.

PMID:
27791337
26.

Oncogene Status of an Interdigitating Dendritic Cell Sarcoma: Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma.

Hillen U, Grabellus F, Franklin C, Sucker A, Schadendorf D, Schilling B.

Am J Surg Pathol. 2016 Dec;40(12):1721-1723. No abstract available.

PMID:
27680605
27.

Purpura fulminans related to paroxysmal nocturnal haemoglobinuria.

Rompoti N, Hillen U, Rösch A, Dissemond J.

Eur J Dermatol. 2016 Aug 1;26(4):397-8. doi: 10.1684/ejd.2016.2786. No abstract available.

PMID:
27046923
28.

Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.

Griewank KG, Schilling B, Scholz SL, Metz CH, Livingstone E, Sucker A, Möller I, Reis H, Franklin C, Cosgarea I, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zimmer L.

Eur J Cancer. 2016 Apr;57:112-7. doi: 10.1016/j.ejca.2016.01.010. Epub 2016 Feb 23.

PMID:
26918736
29.

Current diagnosis and treatment of basal cell carcinoma.

Alter M, Hillen U, Leiter U, Sachse M, Gutzmer R.

J Dtsch Dermatol Ges. 2015 Sep;13(9):863-74; quiz 875. doi: 10.1111/ddg.12798. Review.

PMID:
26882375
30.

Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.

van de Nes J, Gessi M, Sucker A, Möller I, Stiller M, Horn S, Scholz SL, Pischler C, Stadtler N, Schilling B, Zimmer L, Hillen U, Scolyer RA, Buckland ME, Lauriola L, Pietsch T, Waha A, Schadendorf D, Murali R, Griewank KG.

J Neurooncol. 2016 May;127(3):435-44. doi: 10.1007/s11060-015-2052-2. Epub 2016 Jan 7.

31.

Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging.

Stoffels I, Morscher S, Helfrich I, Hillen U, Leyh J, Burton NC, Sardella TC, Claussen J, Poeppel TD, Bachmann HS, Roesch A, Griewank K, Schadendorf D, Gunzer M, Klode J.

Sci Transl Med. 2015 Dec 9;7(317):317ra199. doi: 10.1126/scitranslmed.aad1278. Erratum in: Sci Transl Med. 2015 Dec 23;7(319):319er8. Lehy, Julia [corrected to Leyh, Julia].

PMID:
26659573
32.

Leg ulcers due to foreign body reaction following silicone injections.

Cosgarea I, Gutzeit A, Hillen U, Dissemond J.

J Dtsch Dermatol Ges. 2015 Dec;13(12):1276-8. doi: 10.1111/ddg.12566. Epub 2015 Nov 18. No abstract available.

PMID:
26576694
33.

Sensitization to reactive diluents and hardeners in epoxy resin systems. IVDK data 2002-2011. Part I: reaction frequencies.

Geier J, Lessmann H, Hillen U, Skudlik C, Jappe U.

Contact Dermatitis. 2016 Feb;74(2):83-93. doi: 10.1111/cod.12491. Epub 2015 Nov 5.

PMID:
26538018
34.

Sensitization to reactive diluents and hardeners in epoxy resin systems. IVDK data 2002-2011. Part II: concomitant reactions.

Geier J, Lessmann H, Hillen U, Skudlik C, Jappe U.

Contact Dermatitis. 2016 Feb;74(2):94-101. doi: 10.1111/cod.12490. Epub 2015 Nov 5.

PMID:
26537833
35.

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.

Murali R, Chandramohan R, Möller I, Scholz SL, Berger M, Huberman K, Viale A, Pirun M, Socci ND, Bouvier N, Bauer S, Artl M, Schilling B, Schimming T, Sucker A, Schwindenhammer B, Grabellus F, Speicher MR, Schaller J, Hillen U, Schadendorf D, Mentzel T, Cheng DT, Wiesner T, Griewank KG.

Oncotarget. 2015 Nov 3;6(34):36041-52. doi: 10.18632/oncotarget.5936.

36.

[Should metal alloy discs be used for patch testing in suspected metal implant intolerance reaction?].

Thomas P, Geier J, Dickel H, Diepgen T, Hillen U, Kreft B, Schnuch A, Szliska C, Mahler V.

Orthopade. 2015 Nov;44(11):905-8. doi: 10.1007/s00132-015-3150-8. Review. German.

PMID:
26438196
37.

DKG statement on the use of metal alloy discs for patch testing in suspected intolerance to metal implants.

Thomas P, Geier J, Dickel H, Diepgen T, Hillen U, Kreft B, Schnuch A, Szliska C, Mahler V.

J Dtsch Dermatol Ges. 2015 Oct;13(10):1001-4. doi: 10.1111/ddg.12773. Review.

PMID:
26408461
38.

[DKG statement on the use of metal alloy discs for patch testing in suspected intolerance to metal implants].

Thomas P, Geier J, Dickel H, Diepgen T, Hillen U, Kreft B, Schnuch A, Szliska C, Mahler V.

J Dtsch Dermatol Ges. 2015 Oct;13(10):1001-5. doi: 10.1111/ddg.30_12773. Review. German. No abstract available.

PMID:
26408460
39.

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.

Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MHG, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA.

Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Erratum in: Science. 2015 Nov 13;350(6262):aad8366. Science. 2016 Apr 15;352(6283). pii: aaf8264. doi: 10.1126/science.aaf8264.

40.

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.

Franklin C, Cesko E, Hillen U, Schilling B, Brandau S.

PLoS One. 2015 Aug 4;10(8):e0134518. doi: 10.1371/journal.pone.0134518. eCollection 2015.

41.

[Kikuchi-Fujimoto's disease and adult-onset Still's disease. A rare co-occurence].

Sondermann W, Hillen U, Reis AC, Schimming T, Schilling B.

Hautarzt. 2015 Dec;66(12):940-3. doi: 10.1007/s00105-015-3652-7. German.

PMID:
26115972
42.

Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infection.

Sondermann W, Griewank KG, Schilling B, Livingstone E, Leyh JC, Rompoti N, Cosgarea I, Schimming T, Schadendorf D, Zimmer L, Hillen U.

PLoS One. 2015 Apr 21;10(4):e0124590. doi: 10.1371/journal.pone.0124590. eCollection 2015.

43.

Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions.

Seifert M, Przekopowitz M, Taudien S, Lollies A, Ronge V, Drees B, Lindemann M, Hillen U, Engler H, Singer BB, Küppers R.

Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E546-55. doi: 10.1073/pnas.1416276112. Epub 2015 Jan 26.

44.

Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman.

Livingstone E, Hillen U, Hafner C, Piel S, Groesser L, Schadendorf D, Happle R.

Br J Dermatol. 2015 Jun;172(6):1642-1645. doi: 10.1111/bjd.13562. Epub 2015 Apr 29.

PMID:
25420590
45.

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.

Foss F, Advani R, Duvic M, Hymes KB, Intragumtornchai T, Lekhakula A, Shpilberg O, Lerner A, Belt RJ, Jacobsen ED, Laurent G, Ben-Yehuda D, Beylot-Barry M, Hillen U, Knoblauch P, Bhat G, Chawla S, Allen LF, Pohlman B.

Br J Haematol. 2015 Mar;168(6):811-9. doi: 10.1111/bjh.13222. Epub 2014 Nov 17.

PMID:
25404094
46.

Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al.

Schilling B, Sondermann W, Griewank KG, Livingstone E, Zimmer L, Hillen U, Schadendorf D.

Ann Oncol. 2015 Jan;26(1):250-1; discussion 251-2. doi: 10.1093/annonc/mdu502. Epub 2014 Oct 29. No abstract available.

PMID:
25355721
47.

Painful erythematous plaque with vesicles and pustules.

Cosgarea I, Hillen U, Dissemond J.

J Dtsch Dermatol Ges. 2014 Nov;12(11):1057-9. doi: 10.1111/ddg.12397. Epub 2014 Oct 1. English, German. No abstract available.

PMID:
25272956
48.

Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.

Hillen U, Häusermann P, Massi D, Janin A, Wolff D, Lawitschka A, Greinix H, Meyer R, Ziemer M.

J Eur Acad Dermatol Venereol. 2015 May;29(5):948-54. doi: 10.1111/jdv.12737. Epub 2014 Sep 30.

PMID:
25265987
49.

Angioplasmacellular hyperplasia - a new histopathologic clue for anogenital herpes simplex recidivans in immunocompromised patients?

Schimming TT, Griewank KG, Esser S, Schadendorf D, Hillen U.

Am J Dermatopathol. 2014 Oct;36(10):822-6. doi: 10.1097/DAD.0000000000000070.

PMID:
25243397
50.

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

Griewank KG, Murali R, Puig-Butille JA, Schilling B, Livingstone E, Potrony M, Carrera C, Schimming T, Möller I, Schwamborn M, Sucker A, Hillen U, Badenas C, Malvehy J, Zimmer L, Scherag A, Puig S, Schadendorf D.

J Natl Cancer Inst. 2014 Sep 13;106(9). pii: dju246. doi: 10.1093/jnci/dju246. Print 2014 Sep.

Supplemental Content

Loading ...
Support Center